title: Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified?
abstract: Radical resection remains the only potential curative therapy for hilar cholangiocarcinoma (HCCA). The aim of staging laparoscopic (SL) is to identify patients with previously undetected advanced disease who will not benefit from surgical palliation and therefore avoid unnecessary laparotomies. The accuracy of non-invasive imaging techniques has significantly improved during the last years. As a consequence, the diagnostic yield of SL of biliary tract malignancy should have decreased proportionally. At the same time, some authors have recently questioned the value of laparoscopic ultrasound (LUS) as a complement of SL. In this setting, the precise role of SL and LUS in the preoperative workup of HCCA remains unclear. As it seems undoubtedly clear that its efficacy has decreased in the last decades, there is a general consensus that the universal use of SL shouldn't be recommended anymore; SL should be performed only in selected patients with higher risk of holding unresectable disease (T2/T3 or Bismuth type 3/4 and patients with suspicion of metastases). It would also be recommended in patients with potentially resectable disease who would need preoperative invasive procedures. Finally, SL should be performed preceding laparotomy in one session. Further studies on the benefit of SL and LUS in this subset of HCCA patients are warranted.
authors.affiliation: Fernando Rotellar, Fernando Pardo, HPB and Liver Transplant Unit, Department of General and Abdominal Surgery, University Clinic of Navarre, University of Navarre, 31008 Pamplona, Spain.
authors.forename: Fernando
authors.initials: F
authors.lastname: Rotellar
authors.forename: Fernando
authors.initials: F
authors.lastname: Pardo
keywords: Hilar cholangiocarcinoma; Laparoscopic ultrasound; Laparoscopy; Staging laparoscopy
references.citation: HPB (Oxford). 2008;10(2):116-9
references.pmid: 18773068
references.citation: Ann Surg. 1994 Dec;220(6):709-10
references.pmid: 7986135
references.citation: Ann Surg. 2002 Mar;235(3):392-9
references.pmid: 11882761
references.citation: J Hepatobiliary Pancreat Surg. 2000;7(2):155-62
references.pmid: 10982608
references.citation: Ann Surg. 2002 Jan;235(1):1-7
references.pmid: 11753036
references.citation: Ann Surg. 1999 Aug;230(2):266-75
references.pmid: 10450742
references.citation: J Gastrointest Surg. 2005 Apr;9(4):476-80
references.pmid: 15797226
references.citation: Am J Surg. 2012 Jul;204(1):84-92
references.pmid: 22244586
references.citation: Br J Surg. 2001 Jan;88(1):48-51
references.pmid: 11136309
references.citation: Gastrointest Endosc. 2009 Jan;69(1):55-62
references.pmid: 18657806
references.citation: Ann Surg Oncol. 2011 Sep;18(9):2647-53
references.pmid: 21347792
references.citation: JOP. 2005 Nov 10;6(6):552-61
references.pmid: 16286705
references.citation: Surg Endosc. 2006 May;20(5):721-5
references.pmid: 16508808
references.citation: Ann Surg. 2008 Aug;248(2):273-9
references.pmid: 18650638
references.citation: World J Gastrointest Surg. 2010 Sep 27;2(9):283-90
references.pmid: 21160897
references.citation: J Am Coll Surg. 2009 Jan;208(1):87-95
references.pmid: 19228509
references.citation: J Am Coll Surg. 1999 Jun;188(6):649-55; discussion 655-7
references.pmid: 10359358
references.citation: J Am Coll Surg. 2012 Sep;215(3):343-55
references.pmid: 22749003
references.citation: Ann Surg. 1999 Dec;230(6):808-18; discussion 819
references.pmid: 10615936
references.citation: J Gastrointest Surg. 2002 May-Jun;6(3):426-30; discussion 430-1
references.pmid: 12022996
references.citation: J Clin Oncol. 1997 Mar;15(3):947-54
references.pmid: 9060532
references.citation: Br J Surg. 1994 Jan;81(1):5-6
references.pmid: 8313118
references.citation: J Am Coll Surg. 1997 Jul;185(1):33-9
references.pmid: 9208958
references.citation: Eur J Surg Oncol. 2010 Oct;36(10):941-8
references.pmid: 20547445
references.citation: Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9
references.pmid: 11573044